首页 > 最新文献

Hematology and cell therapy最新文献

英文 中文
Primary MALT lymphoma of the kidney. 肾脏原发性MALT淋巴瘤。
Pub Date : 1999-11-01 DOI: 10.1007/s00282-999-0229-x
M Colović, J Hadzi-Djokić, V Cemerikić, R Colović, G Janković, M Dacić

A primary mucosa associated lymphoid tissue tumor (MALT) of the kidney in a 50-year-old man who suffered from on therapy resistant high blood pressure over 15 years period is presented. A mass in the right kidney (6x5x3 cm) during routine check up was discovered on ultrasonography and confirmed on CT scan and NMR. The patient was submitted to nephrectomy. A mass involving kidney, pyelon and upper part of the ureter was found. Histology showed low grade non-Hodgkin B-cell lymphoma of MALT type. The neoplastic cells were positive for monoclonal antibodies CD20, CD79alpha, surface and cytoplasmic and IgM immunoglobulins and showed light chain restriction (kappa+). After histology was available, a careful staging was performed. The disease was not found anywhere else. It was concluded that the patient belonged to the stage IE of primary kidney MALT lymphoma. Gastroscopy showed signs of chronic superficial gastritis. Urease test was positive and IgG antibodies against Helicobacter pylori in titer 421 were found as well. Except for Helicobacter pylori no additional therapy was given.

本文报道一例50岁男性原发性粘膜相关淋巴组织肿瘤(MALT),他患有顽固性高血压超过15年。常规检查时发现右肾肿块(6x5x3 cm),经CT扫描和核磁共振证实。患者接受肾切除术。发现一肿块累及肾脏、肾盂及输尿管上部。组织学表现为MALT型低级别非霍奇金b细胞淋巴瘤。肿瘤细胞单克隆抗体CD20、cd79 α、表面和细胞质及IgM免疫球蛋白阳性,呈轻链限制性反应(kappa+)。在获得组织学资料后,进行仔细的分期。这种疾病在其他地方没有发现。结论:该患者属于原发性肾MALT淋巴瘤IE期。胃镜检查显示慢性浅表性胃炎。尿素酶试验阳性,检出抗幽门螺杆菌IgG抗体,滴度421。除幽门螺杆菌外,未给予其他治疗。
{"title":"Primary MALT lymphoma of the kidney.","authors":"M Colović,&nbsp;J Hadzi-Djokić,&nbsp;V Cemerikić,&nbsp;R Colović,&nbsp;G Janković,&nbsp;M Dacić","doi":"10.1007/s00282-999-0229-x","DOIUrl":"https://doi.org/10.1007/s00282-999-0229-x","url":null,"abstract":"<p><p>A primary mucosa associated lymphoid tissue tumor (MALT) of the kidney in a 50-year-old man who suffered from on therapy resistant high blood pressure over 15 years period is presented. A mass in the right kidney (6x5x3 cm) during routine check up was discovered on ultrasonography and confirmed on CT scan and NMR. The patient was submitted to nephrectomy. A mass involving kidney, pyelon and upper part of the ureter was found. Histology showed low grade non-Hodgkin B-cell lymphoma of MALT type. The neoplastic cells were positive for monoclonal antibodies CD20, CD79alpha, surface and cytoplasmic and IgM immunoglobulins and showed light chain restriction (kappa+). After histology was available, a careful staging was performed. The disease was not found anywhere else. It was concluded that the patient belonged to the stage IE of primary kidney MALT lymphoma. Gastroscopy showed signs of chronic superficial gastritis. Urease test was positive and IgG antibodies against Helicobacter pylori in titer 421 were found as well. Except for Helicobacter pylori no additional therapy was given.</p>","PeriodicalId":73231,"journal":{"name":"Hematology and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00282-999-0229-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21505898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 26
Splenic lymphoma with villous lymphocytes: dissociated response with fludarabin. 伴绒毛淋巴细胞的脾淋巴瘤:氟达拉滨解离性反应。
Pub Date : 1999-11-01 DOI: 10.1007/s00282-999-0233-1
X Tchiknavorian, J Otto, X Pivot, M C Arnaud, M Schneider, A Thyss
{"title":"Splenic lymphoma with villous lymphocytes: dissociated response with fludarabin.","authors":"X Tchiknavorian,&nbsp;J Otto,&nbsp;X Pivot,&nbsp;M C Arnaud,&nbsp;M Schneider,&nbsp;A Thyss","doi":"10.1007/s00282-999-0233-1","DOIUrl":"https://doi.org/10.1007/s00282-999-0233-1","url":null,"abstract":"","PeriodicalId":73231,"journal":{"name":"Hematology and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00282-999-0233-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21505899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Changes in AgNOR configurations during the evolution and treatment of chronic lymphocytic leukemia. 慢性淋巴细胞白血病的发展和治疗过程中AgNOR结构的变化。
Pub Date : 1999-11-01 DOI: 10.1007/s00282-999-0205-5
K Metze, A C Chiari, F L Andrade, I Lorand-Metze

The evolution of the pattern of nucleolar organiser regions (AgNORs) in circulating lymphocytes during the stable phase and after chemotherapy in CLL was analysed. Peripheral blood smears were stained by the AgNOR technique at diagnosis, during observation follow-up in stable phase, or at the beginning and at the end of chemotherapy in patients with progressive disease. The changes in the AgNOR pattern were compared with those of TTM used as a tumour burden parameter. Among 52 cases that entered the study, 29 were in stable phase and 23 had progressive disease and received chemotherapy. During stable phase, the AgNORs as well as TTM remained constant. In treated patients, the relative reduction of tumour mass was correlated with a decrease in the percentage of lymphocytes containing one AgNOR cluster. The percentage of cells with one compact nucleolus before chemotherapy was inversely correlated with the relative amount of tumor reduction after treatment. We conclude that the AgNOR pattern in CLL describes the cell kinetic changes during the evolution of the disease and is a prognostic factor for tumor reduction after treatment.

分析了慢性淋巴细胞白血病(CLL)稳定期和化疗后循环淋巴细胞核仁组织者区(AgNORs)模式的演变。在诊断时、稳定期观察随访期间、进展性疾病患者化疗开始和结束时,采用AgNOR技术对外周血涂片进行染色。将AgNOR模式的变化与作为肿瘤负荷参数的TTM的变化进行比较。在进入研究的52例患者中,29例处于稳定期,23例病情进展并接受化疗。在稳定阶段,AgNORs和TTM保持不变。在接受治疗的患者中,肿瘤体积的相对减小与含有一个AgNOR簇的淋巴细胞百分比的降低相关。化疗前具有一个致密核仁的细胞百分比与治疗后肿瘤的相对缩小量呈负相关。我们得出结论,CLL中的AgNOR模式描述了疾病演变过程中的细胞动力学变化,是治疗后肿瘤减少的预后因素。
{"title":"Changes in AgNOR configurations during the evolution and treatment of chronic lymphocytic leukemia.","authors":"K Metze,&nbsp;A C Chiari,&nbsp;F L Andrade,&nbsp;I Lorand-Metze","doi":"10.1007/s00282-999-0205-5","DOIUrl":"https://doi.org/10.1007/s00282-999-0205-5","url":null,"abstract":"<p><p>The evolution of the pattern of nucleolar organiser regions (AgNORs) in circulating lymphocytes during the stable phase and after chemotherapy in CLL was analysed. Peripheral blood smears were stained by the AgNOR technique at diagnosis, during observation follow-up in stable phase, or at the beginning and at the end of chemotherapy in patients with progressive disease. The changes in the AgNOR pattern were compared with those of TTM used as a tumour burden parameter. Among 52 cases that entered the study, 29 were in stable phase and 23 had progressive disease and received chemotherapy. During stable phase, the AgNORs as well as TTM remained constant. In treated patients, the relative reduction of tumour mass was correlated with a decrease in the percentage of lymphocytes containing one AgNOR cluster. The percentage of cells with one compact nucleolus before chemotherapy was inversely correlated with the relative amount of tumor reduction after treatment. We conclude that the AgNOR pattern in CLL describes the cell kinetic changes during the evolution of the disease and is a prognostic factor for tumor reduction after treatment.</p>","PeriodicalId":73231,"journal":{"name":"Hematology and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00282-999-0205-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21505981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Unfractionated peripheral blood stem cell autografts and CD(34+)-enriched autografts have similar long-term culture initiating capacity in multiple myeloma. 未分离的自体外周血干细胞和富含CD(34+)的自体移植物在多发性骨髓瘤中具有相似的长期培养启动能力。
Pub Date : 1999-11-01 DOI: 10.1007/s00282-999-0197-1
A G Turhan, J H Bourhis, M L Bonnet, S Novault, C Bayle, A Bennaceur, W Vainchenker, J L Pico, F Beaujean

CD(34+)-enriched peripheral blood stem cells (PBSC) are increasingly being used as an autograft in patients with multiple myeloma (MM). The rationale for the use of the CD34+-enriched fraction in MM is the ability to obtain a graft with a significant reduction of contamination by plasma cells. However, the effect of such a manipulation on the proliferating potential of the engrafted cells is not known. We wished to study, as part of a randomized trial comparing the outcome in MM patients transplanted with either CD(34+)-enriched cells or unfractionated PBSC, the primitive hematopoietic cell content of the autografts using long-term culture initiating cell (LTC-IC) assays in 7 MM patients. In 3 patients CD(34+)cell-enriched fraction was compared to unfractionated PBSC whereas in the remaining 4 patients the LTC-IC assay was performed on total PBSC. The mean percentage of CD34+ cells of the CD34+ selected fraction in three patients was 82% (range 71%-96%) whereas the same percentage in PBSC varied from 0.6% to 10% in 4 patients (mean: 4.2%). Out of three patients transplanted with CD34+ cell fraction, two patients were found to have a very similar LTC-IC generating potential in their CD34+ versus PBSC fractions as this was assessed by the clonogenic cell output at week+5 per 10(4) CD34+ cells initiating the culture (PBSC: 92 and 168 and CD34+ fraction: 102 and 16, respectively) whereas one patient had a slightly different values (PBSC: 51 and CD34+ fraction: 103). When the PBSC fraction was compared in all 7 patients, the LTC-IC generation potential was very heterogenous, varying from 1.4 to 168. To determine if the selection procedure influences the numbers of LTC-IC's in both fractions, we have performed limiting dilution assays to determine both the frequency of distribution of hematopoietic colonies and the frequency of LTC-IC's in two patients. The frequency of distribution of hematopoietic colonies was linear in both CD34+ and PBSC fractions as was the frequency of LTC-IC when the corrections were made with regard to the CD34+ cell-content of the cultures (1/20). Our results indicate that the CD34+ selection procedure used in all three patients (Ceprate) is not deleterious for the generation of LTC-IC's and these findings support the rationale for the use of this procedure in multiple for the purposes of tumor depletion.

富集CD(34+)的外周血干细胞(PBSC)越来越多地被用作多发性骨髓瘤(MM)患者的自体移植物。在MM中使用CD34+富集部分的基本原理是能够获得具有显著减少浆细胞污染的移植物。然而,这种操作对移植细胞增殖潜能的影响尚不清楚。作为一项随机试验的一部分,我们希望通过长期培养起始细胞(LTC-IC)测定7名MM患者自体移植物的原始造血细胞含量,比较移植CD(34+)富集细胞或未分离PBSC的MM患者的结果。在3例患者中,将CD(34+)细胞富集部分与未分离的PBSC进行比较,而在其余4例患者中,对总PBSC进行LTC-IC测定。在3例患者中,CD34+选择部分中CD34+细胞的平均百分比为82%(范围为71%-96%),而在4例患者中,PBSC中相同的百分比从0.6%到10%不等(平均:4.2%)。在三名移植了CD34+细胞片段的患者中,两名患者的CD34+与PBSC片段具有非常相似的LTC-IC生成潜力,这是通过在第5周每10(4)个CD34+细胞开始培养时的克隆生成细胞数量来评估的(PBSC: 92和168,CD34+片段:102和16),而一名患者的值略有不同(PBSC: 51和CD34+片段:103)。当比较所有7例患者的PBSC分数时,LTC-IC生成电位非常不均匀,从1.4到168不等。为了确定选择过程是否会影响两个部分中LTC-IC的数量,我们进行了限制性稀释试验,以确定两个患者中造血菌落分布的频率和LTC-IC的频率。造血集落的分布频率在CD34+和PBSC分数中都是线性的,当对培养物的CD34+细胞含量进行校正时,LTC-IC的频率也是线性的(1/20)。我们的研究结果表明,在所有3例患者中使用的CD34+选择程序(Ceprate)对LTC-IC的产生没有危害,这些发现支持了在多种情况下使用该程序以消除肿瘤的基本原理。
{"title":"Unfractionated peripheral blood stem cell autografts and CD(34+)-enriched autografts have similar long-term culture initiating capacity in multiple myeloma.","authors":"A G Turhan,&nbsp;J H Bourhis,&nbsp;M L Bonnet,&nbsp;S Novault,&nbsp;C Bayle,&nbsp;A Bennaceur,&nbsp;W Vainchenker,&nbsp;J L Pico,&nbsp;F Beaujean","doi":"10.1007/s00282-999-0197-1","DOIUrl":"https://doi.org/10.1007/s00282-999-0197-1","url":null,"abstract":"<p><p>CD(34+)-enriched peripheral blood stem cells (PBSC) are increasingly being used as an autograft in patients with multiple myeloma (MM). The rationale for the use of the CD34+-enriched fraction in MM is the ability to obtain a graft with a significant reduction of contamination by plasma cells. However, the effect of such a manipulation on the proliferating potential of the engrafted cells is not known. We wished to study, as part of a randomized trial comparing the outcome in MM patients transplanted with either CD(34+)-enriched cells or unfractionated PBSC, the primitive hematopoietic cell content of the autografts using long-term culture initiating cell (LTC-IC) assays in 7 MM patients. In 3 patients CD(34+)cell-enriched fraction was compared to unfractionated PBSC whereas in the remaining 4 patients the LTC-IC assay was performed on total PBSC. The mean percentage of CD34+ cells of the CD34+ selected fraction in three patients was 82% (range 71%-96%) whereas the same percentage in PBSC varied from 0.6% to 10% in 4 patients (mean: 4.2%). Out of three patients transplanted with CD34+ cell fraction, two patients were found to have a very similar LTC-IC generating potential in their CD34+ versus PBSC fractions as this was assessed by the clonogenic cell output at week+5 per 10(4) CD34+ cells initiating the culture (PBSC: 92 and 168 and CD34+ fraction: 102 and 16, respectively) whereas one patient had a slightly different values (PBSC: 51 and CD34+ fraction: 103). When the PBSC fraction was compared in all 7 patients, the LTC-IC generation potential was very heterogenous, varying from 1.4 to 168. To determine if the selection procedure influences the numbers of LTC-IC's in both fractions, we have performed limiting dilution assays to determine both the frequency of distribution of hematopoietic colonies and the frequency of LTC-IC's in two patients. The frequency of distribution of hematopoietic colonies was linear in both CD34+ and PBSC fractions as was the frequency of LTC-IC when the corrections were made with regard to the CD34+ cell-content of the cultures (1/20). Our results indicate that the CD34+ selection procedure used in all three patients (Ceprate) is not deleterious for the generation of LTC-IC's and these findings support the rationale for the use of this procedure in multiple for the purposes of tumor depletion.</p>","PeriodicalId":73231,"journal":{"name":"Hematology and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00282-999-0197-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21505982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Therapy related acute myeloid leukemia after exposure to 5-fluorouracil: a case report. 5-氟尿嘧啶暴露后治疗相关急性髓系白血病1例报告
Pub Date : 1999-11-01 DOI: 10.1007/s00282-999-0195-3
A Turker, N Güler

Therapy related acute myeloid leukemia occurs after exposure to various cytotoxic agents. Among typical chemotherapeutic agents are the alkylating agents and topoisomerase II inhibitors. This type of leukemia has been reported after the use of antimetabolites. We report here a patient who developed therapy related acute myeloid leukemia secondary to the use of 5-fluorouracil.

治疗相关的急性髓性白血病发生在暴露于各种细胞毒性药物后。典型的化疗药物有烷基化剂和拓扑异构酶II抑制剂。这种类型的白血病在使用抗代谢物后已有报道。我们在这里报告一个病人谁发展治疗相关急性髓系白血病继发使用5-氟尿嘧啶。
{"title":"Therapy related acute myeloid leukemia after exposure to 5-fluorouracil: a case report.","authors":"A Turker,&nbsp;N Güler","doi":"10.1007/s00282-999-0195-3","DOIUrl":"https://doi.org/10.1007/s00282-999-0195-3","url":null,"abstract":"<p><p>Therapy related acute myeloid leukemia occurs after exposure to various cytotoxic agents. Among typical chemotherapeutic agents are the alkylating agents and topoisomerase II inhibitors. This type of leukemia has been reported after the use of antimetabolites. We report here a patient who developed therapy related acute myeloid leukemia secondary to the use of 5-fluorouracil.</p>","PeriodicalId":73231,"journal":{"name":"Hematology and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00282-999-0195-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21505980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Comparison of the classical manual pushed wedge films, with an improved automated method for making blood smears. 比较经典的手动推楔形膜,与改进的自动化方法,使血液涂片。
Pub Date : 1999-11-01 DOI: 10.1007/s00282-999-0211-7
L Benattar, G Flandrin

Comparison of apparatus for automatically spreading peripheral blood films (GENES) to manual wedge-pull technique has been performed, showing that the average size of optimal area for counting is twice larger in automated smears compared to manual ones. The variability of WBC repartition has been studied in doing differential count on manual and automated smears and both are compared to results obtain with an independent technique (Coulter STKS) for differential. The correlation coefficients for each WBC population show a closer relationship between automated smear preparations and reference instrument (STKS) than with manual spreading smears. Monocyte differential is particularly influenced by the variability of manual spreading procedures.

将自动涂布外周血膜(GENES)的仪器与人工楔拉技术进行了比较,结果表明,自动涂布的最佳计数区域的平均大小是人工涂布的两倍。在手工和自动涂片上进行差异计数时,研究了白细胞再分配的可变性,并将两者与独立技术(Coulter STKS)的差异结果进行了比较。每个白细胞群的相关系数显示,自动涂片制备与参考仪器(STKS)之间的关系比人工涂片更密切。单核细胞的差异特别受到人工扩散过程的可变性的影响。
{"title":"Comparison of the classical manual pushed wedge films, with an improved automated method for making blood smears.","authors":"L Benattar,&nbsp;G Flandrin","doi":"10.1007/s00282-999-0211-7","DOIUrl":"https://doi.org/10.1007/s00282-999-0211-7","url":null,"abstract":"<p><p>Comparison of apparatus for automatically spreading peripheral blood films (GENES) to manual wedge-pull technique has been performed, showing that the average size of optimal area for counting is twice larger in automated smears compared to manual ones. The variability of WBC repartition has been studied in doing differential count on manual and automated smears and both are compared to results obtain with an independent technique (Coulter STKS) for differential. The correlation coefficients for each WBC population show a closer relationship between automated smear preparations and reference instrument (STKS) than with manual spreading smears. Monocyte differential is particularly influenced by the variability of manual spreading procedures.</p>","PeriodicalId":73231,"journal":{"name":"Hematology and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00282-999-0211-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21505983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Conception and organisation of a cell therapy unit of Nantes, France. 概念和组织细胞治疗单位的南特,法国。
Pub Date : 1999-11-01 DOI: 10.1007/s00282-999-0223-3
S Bercegeay, A Cassidanius, C Darmon, F Dehaut, P Lemarre, M C Pandolfino, B Dréno

Manufacturing of cell therapy products has to follow several requirements to obtain sanitary security and quality of the product. Thus, at its conception, the cell therapy unit (CTU) of Nantes choose to integrate a quality assurance system: - The good manufacturing practices (GMP's) are a technical reference for the Unit. They are a quality criteria necessary to guarantee the security of products in term of staff, premises, material, matter and method; - The ISO 9001 standards are a model for quality assurance in design, development, production, installation and servicing. They established a quality system; - The creation, the running and the maintenance of premises are an essential aspect of the quality system and they are described in this paper. Thus, from October 1994 to June 1998, 450 cell processing (with or without cryopreservation and storage of cells) have been realised at the CTU of Nantes, leading to 160 injections without major undesirable effect and without microbiological contamination.

细胞治疗产品的生产必须遵循几项要求,以获得产品的卫生安全和质量。因此,在构思中,南特细胞治疗单位(CTU)选择整合质量保证体系:-良好生产规范(GMP)是该单位的技术参考。它们是保证产品在人员、场所、材料、物质和方法方面安全所必需的质量标准;- ISO 9001标准是设计、开发、生产、安装和服务质量保证的典范。他们建立了质量体系;-场所的创建、运行和维护是质量体系的一个重要方面,本文对此进行了描述。因此,从1994年10月到1998年6月,在南特CTU进行了450次细胞处理(有或没有冷冻保存和储存细胞),进行了160次注射,没有重大不良影响,也没有微生物污染。
{"title":"Conception and organisation of a cell therapy unit of Nantes, France.","authors":"S Bercegeay,&nbsp;A Cassidanius,&nbsp;C Darmon,&nbsp;F Dehaut,&nbsp;P Lemarre,&nbsp;M C Pandolfino,&nbsp;B Dréno","doi":"10.1007/s00282-999-0223-3","DOIUrl":"https://doi.org/10.1007/s00282-999-0223-3","url":null,"abstract":"<p><p>Manufacturing of cell therapy products has to follow several requirements to obtain sanitary security and quality of the product. Thus, at its conception, the cell therapy unit (CTU) of Nantes choose to integrate a quality assurance system: - The good manufacturing practices (GMP's) are a technical reference for the Unit. They are a quality criteria necessary to guarantee the security of products in term of staff, premises, material, matter and method; - The ISO 9001 standards are a model for quality assurance in design, development, production, installation and servicing. They established a quality system; - The creation, the running and the maintenance of premises are an essential aspect of the quality system and they are described in this paper. Thus, from October 1994 to June 1998, 450 cell processing (with or without cryopreservation and storage of cells) have been realised at the CTU of Nantes, leading to 160 injections without major undesirable effect and without microbiological contamination.</p>","PeriodicalId":73231,"journal":{"name":"Hematology and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00282-999-0223-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21505985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Molecular basis to understand polyploidy. 了解多倍体的分子基础。
Pub Date : 1999-08-01 DOI: 10.1007/s00282-999-0169-5
S Baatout

Polyploidy which is defined as an increase in chromosome number by an exact multiple of the haploid chromosome number is a typical characteristic of plant species but can also be found in almost all organisms from protists to humans. In the plant kingdom, since the reproduction can occur vegetatively, polyploid cells have time to settle down from the evolution point of view as a stable genetic system. So, 30 to 70% of angiosperms, including many important crop plants, are estimated to have polyploidy in their lineages. The success of polyploid species in plants has been attributed to their ability to colonise a wider range of habitats and to survive better in unstable climates compared with their diploid progenitors, presumably due to increased heterozygosity and flexibility provided by the presence of additional alleles.

多倍体被定义为染色体数目增加为单倍体数目的精确倍数,是植物物种的典型特征,但也可以在从原生生物到人类的几乎所有生物中发现。在植物界,多倍体细胞作为一种稳定的遗传系统,从进化的角度来看,由于繁殖可以以营养方式进行,多倍体细胞有时间稳定下来。因此,据估计,30%到70%的被子植物,包括许多重要的作物植物,在其谱系中具有多倍体。多倍体物种在植物中的成功被归因于它们比二倍体祖先更有能力在更广泛的栖息地定居,并在不稳定的气候下更好地生存,这可能是由于额外等位基因的存在增加了杂合性和灵活性。
{"title":"Molecular basis to understand polyploidy.","authors":"S Baatout","doi":"10.1007/s00282-999-0169-5","DOIUrl":"https://doi.org/10.1007/s00282-999-0169-5","url":null,"abstract":"<p><p>Polyploidy which is defined as an increase in chromosome number by an exact multiple of the haploid chromosome number is a typical characteristic of plant species but can also be found in almost all organisms from protists to humans. In the plant kingdom, since the reproduction can occur vegetatively, polyploid cells have time to settle down from the evolution point of view as a stable genetic system. So, 30 to 70% of angiosperms, including many important crop plants, are estimated to have polyploidy in their lineages. The success of polyploid species in plants has been attributed to their ability to colonise a wider range of habitats and to survive better in unstable climates compared with their diploid progenitors, presumably due to increased heterozygosity and flexibility provided by the presence of additional alleles.</p>","PeriodicalId":73231,"journal":{"name":"Hematology and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00282-999-0169-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21404201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Sinus polyp-associated soft tissue lesion and unilateral blindness: complications of extraction in leukemic patient. 鼻窦息肉相关软组织病变及单侧失明:白血病患者拔牙术的并发症。
Pub Date : 1999-08-01 DOI: 10.1007/s00282-999-0179-3
A Açikgöz, S Kayipmaz, G Cayir Keles

A case of an inflammatory polyp-associated lesion extending through an extraction socket appearing as an intraoral nodular lesion and unilateral blindness secondary to leukemic optic nerve head infiltration is reported. The patient was a 28-year-old male whose his upper first molar had been extracted fifteen days previously. The lesion was an asymptomatic soft tissue mass, red in color and hot tender to palpation, involving the alveolar ridge in the maxillary molar area. Although this is apparently a rare occurrence, the nature of the lesion was suggested by the history, clinical appearance, and radiographic findings. Excision of the inflammatory lesion was followed by complete healing with closure of the lesion. Unfortunately, the blindness was irreversible. The patient is still under leukemia therapy. Review of the literature did not yield any other such cases. The role of oral lesions as a diagnostic indicator and the importance of dental surgeons in the diagnosis of leukemic patients are discussed. It is concluded that proper precautions and meticulous early diagnosis are required in these patients and that dental practitioners should be aware of the diagnostic features and possibilities of oral complications associated with leukemia.

一例炎性息肉相关病变延伸通过拔牙窝表现为口腔内结节病变和继发于白血病视神经头浸润的单侧失明。患者是一名28岁的男性,他的上第一磨牙是在15天前拔除的。病变为无症状软组织肿块,颜色红色,触诊热压痛,累及上颌磨牙区牙槽嵴。虽然这种情况很少见,但从病史、临床表现和影像学表现可以看出病变的性质。切除炎性病变后,完全愈合并闭合病变。不幸的是,失明是不可逆转的。病人仍在接受白血病治疗。文献回顾未发现其他此类病例。本文讨论了口腔病变作为诊断指标的作用以及口腔外科医生在白血病患者诊断中的重要性。结论:对这些患者应采取适当的预防措施和细致的早期诊断,牙医应了解与白血病相关的口腔并发症的诊断特点和可能性。
{"title":"Sinus polyp-associated soft tissue lesion and unilateral blindness: complications of extraction in leukemic patient.","authors":"A Açikgöz,&nbsp;S Kayipmaz,&nbsp;G Cayir Keles","doi":"10.1007/s00282-999-0179-3","DOIUrl":"https://doi.org/10.1007/s00282-999-0179-3","url":null,"abstract":"<p><p>A case of an inflammatory polyp-associated lesion extending through an extraction socket appearing as an intraoral nodular lesion and unilateral blindness secondary to leukemic optic nerve head infiltration is reported. The patient was a 28-year-old male whose his upper first molar had been extracted fifteen days previously. The lesion was an asymptomatic soft tissue mass, red in color and hot tender to palpation, involving the alveolar ridge in the maxillary molar area. Although this is apparently a rare occurrence, the nature of the lesion was suggested by the history, clinical appearance, and radiographic findings. Excision of the inflammatory lesion was followed by complete healing with closure of the lesion. Unfortunately, the blindness was irreversible. The patient is still under leukemia therapy. Review of the literature did not yield any other such cases. The role of oral lesions as a diagnostic indicator and the importance of dental surgeons in the diagnosis of leukemic patients are discussed. It is concluded that proper precautions and meticulous early diagnosis are required in these patients and that dental practitioners should be aware of the diagnostic features and possibilities of oral complications associated with leukemia.</p>","PeriodicalId":73231,"journal":{"name":"Hematology and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00282-999-0179-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21404874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Infectious complications in chronic lymphocytic leukaemia. 慢性淋巴细胞白血病的感染并发症。
Pub Date : 1999-08-01 DOI: 10.1007/s00282-999-0145-0
E Morra, A Nosari, M Montillo

Infections are the major cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL). Predisposition to infection in CLL is mediated through various abnormalities including both the immune defects inherent in the primary disease (impairment in humoral and cellular immunity) and in the further immunosuppression related to the management of CLL. Hypogammaglobulinemia is probably the most important immune defect in terms of risk of severe bacterial infections, its frequency and severity progressing with the duration of the disease. Newer antineoplastic agents such as purine analogues, especially when used in previously treated patients, may be associated with a new spectrum of pathogens (Listeria monocytogenes, Pneumocystis carinii, cytomegalovirus, herpes simplex virus, and mycobacteria) involving T-cell dysfunction. In this review we focus on the clinical characteristics of infections in CLL and on the risk factors involved in the pathogenesis of this complication. Furthermore, we describe the evolving patterns of infections associated with purine analogues and discuss the currently accepted approaches to prophylaxis and treatment.

感染是慢性淋巴细胞白血病(CLL)患者发病和死亡的主要原因。CLL感染的易感性是通过各种异常介导的,包括原发疾病固有的免疫缺陷(体液和细胞免疫损伤)以及与CLL管理相关的进一步免疫抑制。就严重细菌感染的风险而言,低γ -球蛋白血症可能是最重要的免疫缺陷,其频率和严重程度随着疾病的持续时间而增加。较新的抗肿瘤药物,如嘌呤类似物,特别是在先前治疗过的患者中使用时,可能与涉及t细胞功能障碍的新病原体谱(单核细胞增生李斯特菌、卡氏肺囊虫、巨细胞病毒、单纯疱疹病毒和分枝杆菌)有关。在这篇综述中,我们重点讨论了CLL感染的临床特征以及引起这种并发症的危险因素。此外,我们描述了与嘌呤类似物相关的感染的演变模式,并讨论了目前接受的预防和治疗方法。
{"title":"Infectious complications in chronic lymphocytic leukaemia.","authors":"E Morra,&nbsp;A Nosari,&nbsp;M Montillo","doi":"10.1007/s00282-999-0145-0","DOIUrl":"https://doi.org/10.1007/s00282-999-0145-0","url":null,"abstract":"<p><p>Infections are the major cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL). Predisposition to infection in CLL is mediated through various abnormalities including both the immune defects inherent in the primary disease (impairment in humoral and cellular immunity) and in the further immunosuppression related to the management of CLL. Hypogammaglobulinemia is probably the most important immune defect in terms of risk of severe bacterial infections, its frequency and severity progressing with the duration of the disease. Newer antineoplastic agents such as purine analogues, especially when used in previously treated patients, may be associated with a new spectrum of pathogens (Listeria monocytogenes, Pneumocystis carinii, cytomegalovirus, herpes simplex virus, and mycobacteria) involving T-cell dysfunction. In this review we focus on the clinical characteristics of infections in CLL and on the risk factors involved in the pathogenesis of this complication. Furthermore, we describe the evolving patterns of infections associated with purine analogues and discuss the currently accepted approaches to prophylaxis and treatment.</p>","PeriodicalId":73231,"journal":{"name":"Hematology and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1999-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00282-999-0145-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21404198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 44
期刊
Hematology and cell therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1